financetom
Business
financetom
/
Business
/
Cintas Fiscal Q3 Earnings, Revenue Rise; Lifts Fiscal 2026 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cintas Fiscal Q3 Earnings, Revenue Rise; Lifts Fiscal 2026 Guidance
Mar 25, 2026 6:17 AM

08:59 AM EDT, 03/25/2026 (MT Newswires) -- Cintas ( CTAS ) reported fiscal Q3 earnings Wednesday of $1.24 per diluted share, up from $1.13 a year earlier.

Analysts polled by FactSet expected $1.23.

Revenue for the quarter ended Feb. 28 was $2.84 billion, up from $2.61 billion a year earlier.

Analysts surveyed by FactSet expected $2.82 billion.

Cintas ( CTAS ) said it now expects fiscal 2026 adjusted diluted EPS of $4.86 to $4.90, compared with $4.81 to $4.88 estimated earlier. Analysts polled by FactSet expect $4.87.

Revenue for the current fiscal year is projected to be between $11.21 billion and $11.24 billion, the company said. That compares with the previous guidance of $11.15 billion to $11.22 billion. Analysts surveyed by FactSet expect $11.21 billion.

Shares of the company were 1% higher in recent Wednesday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Antin to Acquire Emsere, a Global Leader in Clinical Trial Equipment Infrastructure
Antin to Acquire Emsere, a Global Leader in Clinical Trial Equipment Infrastructure
Mar 11, 2026
Acquisition is eighth investment by Antin’s Mid Cap Fund I PARIS & LONDON & NEW YORK--(BUSINESS WIRE)-- Regulatory News: Antin Infrastructure Partners has agreed with Dutch family office and investment platform Gryphion to acquire Emsere, a leading medical equipment rental specialist, providing mission-critical medical equipment and service solutions, including specialised logistics for clinical trials globally. The investment will be...
Form 8.3
Form 8.3
Mar 11, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Form 8.3
Form 8.3
Mar 11, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Bridge Specialty Group acquires the assets of Shoemaker & Besser Associates, Inc.
Bridge Specialty Group acquires the assets of Shoemaker & Besser Associates, Inc.
Mar 11, 2026
DAYTONA BEACH, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- J. Scott Penny, chief acquisitions officer of Brown & Brown, Inc. , and Jack Brubaker and L. Allan Boyd, owners of Shoemaker & Besser Associates, Inc. (“Shoemaker & Besser”), today announced that a Bridge Specialty Group company and subsidiary of Brown & Brown, Inc. has acquired the assets of Shoemaker &...
Copyright 2023-2026 - www.financetom.com All Rights Reserved